HK1091756A1 - Uses of interferons with altered spatial structure - Google Patents

Uses of interferons with altered spatial structure

Info

Publication number
HK1091756A1
HK1091756A1 HK06113460.8A HK06113460A HK1091756A1 HK 1091756 A1 HK1091756 A1 HK 1091756A1 HK 06113460 A HK06113460 A HK 06113460A HK 1091756 A1 HK1091756 A1 HK 1091756A1
Authority
HK
Hong Kong
Prior art keywords
interferons
spatial structure
altered spatial
altered
spatial
Prior art date
Application number
HK06113460.8A
Other languages
English (en)
Inventor
Guangwen Wei
Original Assignee
Superlab Far East Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34280101&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1091756(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Superlab Far East Ltd filed Critical Superlab Far East Ltd
Publication of HK1091756A1 publication Critical patent/HK1091756A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
HK06113460.8A 2003-08-28 2006-12-07 Uses of interferons with altered spatial structure HK1091756A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US49892303P 2003-08-28 2003-08-28
US49878503P 2003-08-28 2003-08-28
US49844903P 2003-08-28 2003-08-28
IN280MU2004 2004-03-05
IN279MU2004 2004-03-05
PCT/US2004/028067 WO2005034853A2 (fr) 2003-08-28 2004-08-26 Utilisations d'interferons a structure spatiale modifiee

Publications (1)

Publication Number Publication Date
HK1091756A1 true HK1091756A1 (en) 2007-01-26

Family

ID=34280101

Family Applications (2)

Application Number Title Priority Date Filing Date
HK06113460.8A HK1091756A1 (en) 2003-08-28 2006-12-07 Uses of interferons with altered spatial structure
HK11112807.5A HK1158231A1 (en) 2003-08-28 2011-11-25 Uses of interferons with altered spatial structure

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11112807.5A HK1158231A1 (en) 2003-08-28 2011-11-25 Uses of interferons with altered spatial structure

Country Status (8)

Country Link
EP (3) EP2325202B1 (fr)
JP (4) JP2007503812A (fr)
KR (2) KR20060133949A (fr)
AU (2) AU2004269390A1 (fr)
CA (2) CA2535982C (fr)
HK (2) HK1091756A1 (fr)
PL (2) PL2325202T3 (fr)
WO (2) WO2005034853A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8551469B2 (en) 2001-02-28 2013-10-08 Superlab Far East Limited Treatment of tumors and viral diseases with recombinant interferon alpha
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
EP2325202B1 (fr) * 2003-08-28 2014-10-22 Superlab Far East Limited Utilisations d'interférons à structure spatiale modifiée
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon
WO2006076014A2 (fr) * 2004-04-30 2006-07-20 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Constructions d'interferon-alpha destinees a etre utilisees dans le traitement du sras
MY167668A (en) 2005-03-09 2018-09-21 Superlab Far East Ltd Uses of recombinant super-compound interferons
CN102101886A (zh) * 2009-12-18 2011-06-22 四川辉阳生命工程股份有限公司 构象改变的重组干扰素晶体、其三维结构及应用
TWI718086B (zh) 2013-01-07 2021-02-11 英屬維爾京群島商遠東超級實驗室有限公司 通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
CN111363726A (zh) * 2018-12-26 2020-07-03 上海元宋生物技术有限公司 表达干扰素的溶瘤病毒及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5372808A (en) 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
EP0861321B1 (fr) * 1995-10-13 2006-05-31 President And Fellows Of Harvard College Phosphopantetheinyl transferases et leurs utilisations
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US20020043262A1 (en) * 2000-08-22 2002-04-18 Alan Langford Spray device
US7666995B2 (en) * 2000-11-03 2010-02-23 Pestka Biomedical Laboratories Interferons, uses and compositions related thereto
CN1245215C (zh) * 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
EP2325202B1 (fr) * 2003-08-28 2014-10-22 Superlab Far East Limited Utilisations d'interférons à structure spatiale modifiée

Also Published As

Publication number Publication date
CA2535902A1 (fr) 2005-03-10
JP5709800B2 (ja) 2015-04-30
JP2007516214A (ja) 2007-06-21
KR20060133949A (ko) 2006-12-27
CA2535982C (fr) 2016-11-29
WO2005034853A3 (fr) 2006-04-27
JP2007503812A (ja) 2007-03-01
EP1663110B1 (fr) 2013-12-18
JP2012162567A (ja) 2012-08-30
JP5663768B2 (ja) 2015-02-04
JP2011083292A (ja) 2011-04-28
PL2325202T3 (pl) 2015-03-31
WO2005021777A2 (fr) 2005-03-10
EP2325202B1 (fr) 2014-10-22
AU2004279350B2 (en) 2011-03-10
KR20060130009A (ko) 2006-12-18
EP1670817A4 (fr) 2008-07-16
EP1663110A4 (fr) 2008-07-16
HK1158231A1 (en) 2012-09-14
AU2004269390A1 (en) 2005-03-10
PL1663110T3 (pl) 2014-07-31
WO2005021777A3 (fr) 2005-05-12
EP1663110A2 (fr) 2006-06-07
CA2535982A1 (fr) 2005-04-21
EP2325202A1 (fr) 2011-05-25
AU2004279350A1 (en) 2005-04-21
WO2005034853A2 (fr) 2005-04-21
EP1670817A2 (fr) 2006-06-21

Similar Documents

Publication Publication Date Title
HK1158231A1 (en) Uses of interferons with altered spatial structure
EP1646371A4 (fr) Compositions et methodes antivirales
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
IL175491A0 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
EP1581631A4 (fr) Variants d'interferons presentant des proprietes ameliorees
TW557117U (en) Fin structure and assembly thereof
AU2003242405A1 (en) Compounds and preparaitons having antiviral effect
SI1663110T1 (sl) Uporaba interferonov s spremenjeno prostorsko strukturo
TW559446U (en) Case structure
GB2399859B (en) Stay
TW560284U (en) The improvement of the baggage structure
TW553243U (en) Structure of clotheshanger
TW566211U (en) Structure of Frisbee
TW547741U (en) Improved structure of wanton
TW586441U (en) Structure of luminous Frisbee
TW533774U (en) Structure improvement of flyswatter
TW582544U (en) The improvement of the gradienter structure
TW567775U (en) Structure of hairtie
TW582219U (en) Improved structure of flabellum
TW571665U (en) Improved structure of pensile case
TW564684U (en) Structure of helmet with advertisement effects
GB0323824D0 (en) Structure
TW571835U (en) Sprayer-nozzle structure
TW595659U (en) Improvement of fan structure
TW577292U (en) Structure of chair